Known targets — ChEMBL curated mechanism
GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHMGCRMMP1MMP13MMP7MMP8PTGS1PTGS2ileSpolrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 4/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.32 |
| ▸ | MMP3 | P08254 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2313689 | 0.96 | ALDH1A1 (0.47) | ALDH1A1NOTUMMAPK1RAB9ANPC1 | |
| Iodide SCHEMBL701439 | 0.93 | ALDH1A1 (0.44) | ALDH1A1NOTUMMAPK1RAB9ANPC1 | |
| Hydrochloric Acid SCHEMBL701515 | 0.93 | ALDH1A1 (0.44) | ALDH1A1NOTUMMAPK1RAB9ANPC1 | |
| Bromide SCHEMBL699714 | 0.93 | ALDH1A1 (0.44) | ALDH1A1NOTUMMAPK1RAB9ANPC1 | |
| Hydrochloric Acid SCHEMBL699430 | 0.93 | ALDH1A1 (0.44) | ALDH1A1NOTUMMAPK1RAB9ANPC1 | |
| Bromide SCHEMBL699713 | 0.93 | ALDH1A1 (0.44) | ALDH1A1NOTUMMAPK1RAB9ANPC1 | |
| Fluoride SCHEMBL699471 | 0.93 | ALDH1A1 (0.44) | ALDH1A1NOTUMMAPK1RAB9ANPC1 | |
| Fluoride Ion SCHEMBL699470 | 0.93 | ALDH1A1 (0.44) | ALDH1A1NOTUMMAPK1RAB9ANPC1 | |
| Iodide SCHEMBL701438 | 0.93 | ALDH1A1 (0.44) | ALDH1A1NOTUMMAPK1RAB9ANPC1 | |
| Benzene SCHEMBL31091106 | 0.93 | ALDH1A1 (0.50) | ALDH1A1NOTUMMAPK1RAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1688424-B1 | PHOSPHONIUM BORATE COMPOUND AND METHOD OF USING THE SAME | HOKKO CHEM IND CO (JP) | 2016-01-13 | — | — | EP | disclosed |
| US-8604249-B2 | Process for producing phosphonium borate compound, novel phosphonium borate compound, and method of using the same | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2013-12-10 | — | — | US | disclosed |
| US-8124809-B2 | Process for producing phosphonium borate compound, novel phosphonium borate compound, and method of using the same | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2012-02-28 | — | — | US | disclosed |
| US-20110237799-A1 | Process for Producing Phosphonium Borate Compound, Novel Phosphonium Borate Compound, and Method of Using the Same | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2011-09-29 | — | — | US | disclosed |
| US-20110166389-A1 | Process for Producing Phosphonium Borate Compound, Novel Phosphonium Borate Compound, and Method of Using the Same | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2011-07-07 | — | — | US | disclosed |
| US-7728176-B2 | Process for producing phosphonium borate compound, novel phosphonium borate compound, and method of using the same | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2010-06-01 | — | — | US | disclosed |
| US-20090305877-A1 | Process for producing phosphonium borate compound, novel phosphonium borate compound, and method of using the same | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2009-12-10 | — | — | US | disclosed |
| US-20070098616-A1 | Process for producing phosponium borate compound, novel phosphonium borate compound, and method of using the same | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2007-05-03 | — | — | US | disclosed |
| EP-1688424-A1 | PROCESS FOR PRODUCING PHOSPHONIUM BORATE COMPOUND, NOVEL PHOSPHONIUM BORATE COMPOUND, AND METHOD OF USING THE SAME | HOKKO CHEMICAL INDUSTRY CO. LTD. (JP) | 2006-08-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166389-A1 | Process for Producing Phosphonium Borate Compound, Novel Phosphonium Borate Compound, and Method of Using the Same | CA4, EPB41, MAPK4 | ALDH1A1 4654/4885NOTUM 3101/4885MAPK1 218/4885 |
| US-20110237799-A1 | Process for Producing Phosphonium Borate Compound, Novel Phosphonium Borate Compound, and Method of Using the Same | EPB41, CA4, RBBP4 | ALDH1A1 4626/4885NOTUM 3464/4885MAPK1 278/4885 |
| US-20090305877-A1 | Process for producing phosphonium borate compound, novel phosphonium borate compound, and method of using the same | PHOSPHO1, BRI3BP, CA4 | ALDH1A1 3637/4885NOTUM 1496/4885MAPK1 350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.